Enrollment Completed in Phase 1 Program for XOMA 052 in Type 2 …
April 30th, 2009
| Tags: Arthritis, biotechnology, collaboration, design, development, financial, health, inflammatory, management, newsroom, phase, research, services, uric acid, xoma
“Based on the Phase 1 program, XOMA plans to initiate a multicenter, randomized , placebo- controlled Phase 2 program in Type 2 diabetes in the third quarter of 2009.” Nearly 100 patients were enrolled in Phase 1 trials in the U.S. and Switzerland. The U.S
Read more here:
Enrollment Completed in Phase 1 Program for XOMA 052 in Type 2 …
Leave a comment
| Trackback